Literature DB >> 29421556

Self-indicating, fully active pharmaceutical ingredients nanoparticles (FAPIN) for multimodal imaging guided trimodality cancer therapy.

Xiangdong Xue1, Yee Huang2, Xinshuai Wang1, Zhongling Wang1, Randy P Carney1, Xiaocen Li1, Ye Yuan1, Yixuan He1, Tzu-Yin Lin3, Yuanpei Li4.   

Abstract

Conventional drug delivery systems contain substantial amounts of excipients such as polymers and lipids, typically with low drug loading capacity and lack of intrinsic traceability and multifunctionality. Here, we report fully active pharmaceutical ingredient nanoparticles (FAPIN) which were self-assembled by minimal materials, but seamlessly orchestrated versatile theranostic functionalities including: i) self-delivery: no additional carriers were required, all components in the formulation are active pharmaceutical ingredients; ii) self-indicating: no additional imaging tags were needed. The nanoparticle itself was composed of 100% imaging agents, so that the stability, drug release, subcellular dispositions, biodistribution and therapeutic efficacy of FAPINs can be readily visualized by ample imaging capacities, including energy transfer relay dominated, dual-color fluorogenic property, near-infrared fluorescence imaging and magnetic resonance imaging; and iii) highly effective trimodality cancer therapy, encompassing photodynamic-, photothermal- and chemo-therapies. FAPINs were fabricated with very simple material (a photosensitizer-drug conjugate), unusually achieved ∼10 times better in vitro antitumor activity than their free counterparts, and were remarkably efficacious in patient-derived xenograft (PDX) glioblastoma multiforme animal models. Only two doses of FAPINs enabled complete ablation of highly-malignant PDX tumors in 50% of the mice.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer therapy; Drug delivery; Multi-modal therapy; Nanoparticles; Self-indication

Mesh:

Year:  2018        PMID: 29421556      PMCID: PMC5846343          DOI: 10.1016/j.biomaterials.2018.01.044

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  48 in total

1.  Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient.

Authors:  Jeremy Adler; Ingela Parmryd
Journal:  Cytometry A       Date:  2010-08       Impact factor: 4.355

2.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

Review 3.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

4.  Comparison of methods and achievable uncertainties for the relative and absolute measurement of photoluminescence quantum yields.

Authors:  Christian Würth; Markus Grabolle; Jutta Pauli; Monika Spieles; Ute Resch-Genger
Journal:  Anal Chem       Date:  2011-04-07       Impact factor: 6.986

5.  Aggregation-induced emission: phenomenon, mechanism and applications.

Authors:  Yuning Hong; Jacky W Y Lam; Ben Zhong Tang
Journal:  Chem Commun (Camb)       Date:  2009-05-13       Impact factor: 6.222

6.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

Authors:  Anna Salvati; Andrzej S Pitek; Marco P Monopoli; Kanlaya Prapainop; Francesca Baldelli Bombelli; Delyan R Hristov; Philip M Kelly; Christoffer Åberg; Eugene Mahon; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2013-01-20       Impact factor: 39.213

7.  Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.

Authors:  Teri N Kreisl; Lyndon Kim; Kraig Moore; Paul Duic; Cheryl Royce; Irene Stroud; Nancy Garren; Megan Mackey; John A Butman; Kevin Camphausen; John Park; Paul S Albert; Howard A Fine
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

Review 8.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

Review 9.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

Review 10.  Self-assembling prodrugs.

Authors:  Andrew G Cheetham; Rami W Chakroun; Wang Ma; Honggang Cui
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

View more
  8 in total

1.  A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors.

Authors:  Xiangdong Xue; Ruonan Bo; Haijing Qu; Bei Jia; Wenwu Xiao; Ye Yuan; Natalia Vapniarsky; Aaron Lindstrom; Hao Wu; Dalin Zhang; Longmeng Li; Marina Ricci; Zhao Ma; Zheng Zhu; Tzu-Yin Lin; Angelique Y Louie; Yuanpei Li
Journal:  Biomaterials       Date:  2020-07-15       Impact factor: 12.479

2.  A facile approach to fabricate self-assembled magnetic nanotheranostics for drug delivery and imaging.

Authors:  Ye Yuan; Yixuan He; Ruonan Bo; Zhao Ma; Zhongling Wang; Lijie Dong; Tzu-Yin Lin; Xiangdong Xue; Yuanpei Li
Journal:  Nanoscale       Date:  2018-11-29       Impact factor: 7.790

3.  A polymer-free, biomimicry drug self-delivery system fabricated via a synergistic combination of bottom-up and top-down approaches.

Authors:  Xiaobao Xu; Gaomai Yang; Xiangdong Xue; Hongwei Lu; Hao Wu; Yee Huang; Di Jing; Wenwu Xiao; Jingkui Tian; Wei Yao; Chong-Xian Pan; Tzu-Yin Lin; Yuanpei Li
Journal:  J Mater Chem B       Date:  2018-11-12       Impact factor: 6.331

4.  Iron-crosslinked Rososome with robust stability and high drug loading for synergistic cancer therapy.

Authors:  Xiangdong Xue; Marina Ricci; Haijing Qu; Aaron Lindstrom; Dalin Zhang; Hao Wu; Tzu-Yin Lin; Yuanpei Li
Journal:  J Control Release       Date:  2020-10-08       Impact factor: 9.776

5.  Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment.

Authors:  Xiangdong Xue; Yee Huang; Ruonan Bo; Bei Jia; Hao Wu; Ye Yuan; Zhongling Wang; Zhao Ma; Di Jing; Xiaobao Xu; Weimin Yu; Tzu-Yin Lin; Yuanpei Li
Journal:  Nat Commun       Date:  2018-09-07       Impact factor: 14.919

6.  Conducting Polymeric Nanocomposites with a Three-Dimensional Co-flow Microfluidics Platform.

Authors:  Xiaodong Ma; Yuezhou Zhang; Korbinian Weisensee
Journal:  Micromachines (Basel)       Date:  2019-06-07       Impact factor: 2.891

Review 7.  NIR-I Dye-Based Probe: A New Window for Bimodal Tumor Theranostics.

Authors:  Fan Zheng; Xueyan Huang; Jipeng Ding; Anyao Bi; Shifen Wang; Fei Chen; Wenbin Zeng
Journal:  Front Chem       Date:  2022-03-23       Impact factor: 5.221

Review 8.  Nanotechnology-based combinatorial phototherapy for enhanced cancer treatment.

Authors:  Han Chen; Peter Timashev; Yuanyuan Zhang; Xiangdong Xue; Xing-Jie Liang
Journal:  RSC Adv       Date:  2022-04-04       Impact factor: 3.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.